| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
274 |
231 |
$187K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,529 |
1,435 |
$35K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
554 |
529 |
$24K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
281 |
247 |
$3K |
| 85651 |
|
1,101 |
1,066 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14 |
14 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14 |
14 |
$799.94 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$176.09 |
| 80305 |
|
26 |
26 |
$137.38 |
| J7050 |
Infusion, normal saline solution, 250 cc |
291 |
253 |
$45.20 |
| 36415 |
Collection of venous blood by venipuncture |
504 |
479 |
$14.76 |
| G9359 |
Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier |
24 |
21 |
$0.00 |
| 90756 |
|
30 |
25 |
$0.00 |
| 4192F |
|
41 |
40 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
41 |
36 |
$0.00 |
| M1007 |
>=50% of total number of a patient's outpatient ra encounters assessed |
48 |
47 |
$0.00 |
| 1170F |
|
46 |
45 |
$0.00 |